lot's of companies fit that description and they picked sotk and i doubt it was based on just the double digit guidance they gave for q2. shareholder meeting might be more interesting this year.
they don't seem like a pump/dump firm. and sotk has no IR firm.
yea, i saw that, quite a surprise. last big investor in sotk was norman pessin and his wife who owned about 5.6% but don't report anymore, he is an old fashioned value investor, no games.
it will be fun trying to figure out if there is more going than just bbuy and hold, , tough to unload that many shares.
wonder if sotk got their attn. at that n.y. investor conference, will have to look at trading history.
this investor/adviser has taken large positions in small illiquid companies before but i don't think any otc and sotk seems to be the smallest yet.
wonder if it's his client's money or his own, William F. Nicklin, Manager
By Ken Ribotsky.
Pharmaceutical companies have begun using social media for business needs and promotion, yet have been hesitant to become too engaged since the FDA’s stance on social media activity remained unclear. But now that we know the FDA’s specific guidelines for pharma companies’ actions online, it’s time for brands to consider diving into the social media pool.
What FDA Regulations Mean for You
But before we dive in too deep, here’s a refresher on what the FDA guidelines do:
They clearly define interactive promotional media as “modern tools and technologies that often allow for real-time communications and interactions (e.g., blogs, microblogs, social networking sites, online communities, and live podcasts) and that firms use to promote their drugs.”
They explain that pharma companies are not responsible for user-generated content.
They stress that it’s the company’s responsibility to monitor information disseminated on and throughout its sponsored sites and accounts.
How to Make the Most of Social Media (Within FDA Guidelines)
So, what does that mean for your company?
The FDA guidelines simply outline the proper use and behavior of pharma companies utilizing social media, just as there are guidelines for drug testing, marketing, and label warnings. With this new information, here’s what your company should do:
Establish a company presence on social media. If your brand is not already engaged in social media, start today. It’s a great way to promote products, connect with consumers, and shape the conversation surrounding your brand, rather than let the online community shape it for you.
Pay close attention to alliances with third-party sites. Your company is responsible for any promotion when you have any influence or control on third-party sites. Third parties don’t like to be told what to do, and they often use your material as they see fit — even if it contradicts your original intent. Choose and monitor your partnerships wise
50 day moving avg is 1.09, 200 day moving avg is 1.08 so pretty good support here imho.
your're stating an opinion or do you know something i don't about what motivates peter?
for one thing, the numbers i posted are not official company numbers, peter might own far more shares and i think you have to include options, i assume they come into play in a takeover. so anyway, it seems they haven't filled any of the positions advertised on their website in months so what's that all about, are they just not updating that page? strange imho. keeping that up to date is part of IR.
it would be nice to have updated ownership. at least we know their financials can pass an audit but insider ownership is conspicuously missing. maybe it's out there but i can't find it.
assume 50,000,000 shares including options, not sure if those should be included, but at .20/share that's $10mill market cap, still less than 1x revenue.
the would have to get their financials audited for i think 3 years to uplist? have to check that. and the audited 10k's they put out are still missing things like exec. salaries, insider ownership, bios so one could wildly speculate that another reason besides wanting to raise equity, uplist, prove to customers they were fiscally sound would be to make it easier to sell the company. assume they could get 1.5-2x revenue? of course also depends on tangible assets, IP, management, staff.
very wild speculation here but management ain't getting any younger and i think they control lot of shares/options that aren't very liquid right now.
i've gone onto the SEC website and looked at 10SB12G filed back in 2007, shows friedman with 708,000 shares possibly much more if he exercised options,
someone named jay friedman owning around 2mill, some other non-employee large owners, so anyone have a link to docs, with more current numbers?
sorry if i missed something obvious here.
i actually own STWS just as a trade because they give great hype but financials are a mess, but they might actually deliver on the hype, who knows? i posted this because they partnered with TMEN, seems like it was a brief partnership or are they still friends? doesn't seem so. these are the deals TMEN was supposed to get? assuming they are real deals.
i'm not so sure about gelbaum, he may have lost most of his wealth, hundreds of millions, investing in +30 speculative investments including over $50mill on entech -he's still their ceo and single board member, share price around .003 - so imho you aren't convincing anyone by using his wisdom as part of that argument. no doubt he's brilliant but what bad luck. enuf said, best of luck, just had to respond to the world's 2nd worst pumper ghvann1
based on history, the stock usually goes down when ghvann1 posts. now that i think about it, the stock goes down when anyone posts, my bad.
what i don't understand is why gelbaum hasn't sold his shares, he's baled out of other companies and taken a loss, EFOI, AXPW.
link on their twitter or facebook pages which have to be checked everyday it seems. no surviving the recession talk.
i assumed they would post something before the conference.